Pages that link to "Q42151567"

The following pages link to Quantitative autoradiography of hippocampal GABAB and GABAA receptor changes in Alzheimer's disease (Q42151567):

Displaying 26 items.

• GABA(B) receptor autoradiography in hippocampal sclerosis associated with human temporal lobe epilepsy (Q28346398) (← links)
• GABABR1 receptor protein expression in human mesial temporal cortex: changes in temporal lobe epilepsy (Q34138555) (← links)
• CHF2819: pharmacological profile of a novel acetylcholinesterase inhibitor. (Q34692013) (← links)
• Studies of GABA(B) receptors labelled with [(3)H]-CGP62349 in hippocampus resected from patients with temporal lobe epilepsy. (Q35044501) (← links)
• Implications for treatment: GABAA receptors in aging, Down syndrome and Alzheimer’s disease (Q35079696) (← links)
• GABAergic function in Alzheimer's disease: evidence for dysfunction and potential as a therapeutic target for the treatment of behavioural and psychological symptoms of dementia (Q35884948) (← links)
• Microtransplantation of functional receptors and channels from the Alzheimer's brain to frog oocytes (Q36162347) (← links)
• Inhibiting BACE1 to reverse synaptic dysfunctions in Alzheimer's disease (Q36869427) (← links)
• The dentate gyrus in Alzheimer's disease (Q36926921) (← links)
• Amyloid-β induces synaptic dysfunction through G protein-gated inwardly rectifying potassium channels in the fimbria-CA3 hippocampal synapse. (Q37043451) (← links)
• Opioid System and Alzheimer’s Disease (Q38004941) (← links)
• Alzheimer's disease: clinical and pathological characteristics (Q38015627) (← links)
• GABAergic neurotransmission and new strategies of neuromodulation to compensate synaptic dysfunction in early stages of Alzheimer's disease (Q38225536) (← links)
• Excitatory amino acid binding sites in the hippocampal region of Alzheimer's disease and other dementias (Q41200060) (← links)
• Diazepam impairs retention of spatial information without affecting retrieval or cue learning (Q41901990) (← links)
• First one in, last one out: the role of GABAergic transmission in generation and degeneration (Q42458417) (← links)
• Biochemical analysis of GABA(A) receptor subunits alpha 1, alpha 5, beta 1, beta 2 in the hippocampus of patients with Alzheimer's disease neuropathology (Q47718530) (← links)
• Immunohistochemical study of GABAA receptor α1 subunit in the hippocampal formation of aged brains with Alzheimer-related neuropathologic changes (Q47836611) (← links)
• Mu opioids enhance mossy fiber synaptic transmission indirectly by reducing GABAB receptor activation (Q48271412) (← links)
• GABAA receptor β2 and β3 subunits mRNA in the hippocampal formation of aged human brain with Alzheimer-related neuropathology (Q48462010) (← links)
• Immunohistochemical Study of GABAAReceptor β2/3 Subunits in the Hippocampal Formation of Aged Brains with Alzheimer-Related Neuropathologic Changes (Q48607146) (← links)
• Differential effects of aging on EEG after baclofen administration (Q52298703) (← links)
• Density and pharmacology of alpha5 subunit-containing GABA(A) receptors are preserved in hippocampus of Alzheimer's disease patients. (Q53236378) (← links)
• Preclinical progress with CHF2819, a novel orally active acetylcholinesterase inhibitor (Q63437487) (← links)
• Immunohistochemical localization of gamma-aminobutyric acid(B) receptor in the hippocampus of subjects with schizophrenia (Q73598941) (← links)
• Influence of hippocampal GABAB receptor inhibition on memory in rats with acute β-amyloid toxicity (Q90433497) (← links)